AustralieFrV1, PubMed, Corpus, bibRecord, 001E84

Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.

Identifieur interne : 001E84 ( PubMed/Corpus ); précédent : 001E83; suivant : 001E85

Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.

Auteurs : Bernhard Reis ; Lori Jukofsky ; Gong Chen ; Giovanni Martinelli ; Hua Zhong ; W Venus So ; Michael J. Dickinson ; Mark Drummond ; Sarit Assouline ; Maneja Hashemyan ; Michel Theron ; Steven Blotner ; Je-Hwan Lee ; Margaret Kasner ; Sung-Soo Yoon ; Ruediger Rueger ; Karen Seiter ; Steven A. Middleton ; Kevin R. Kelly ; Norbert Vey ; Karen Yee ; Gwen Nichols ; Lin-Chi Chen ; William E. Pierceall

Source :

Haematologica [ 1592-8721 ] ; 2016.

RBID : pubmed:26869629
DOI: 10.3324/haematol.2015.139717
PubMed: 26869629

Links to Exploration step

pubmed:26869629

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.</title>
<author><name sortKey="Reis, Bernhard" sort="Reis, Bernhard" uniqKey="Reis B" first="Bernhard" last="Reis">Bernhard Reis</name>
<affiliation><nlm:affiliation>Roche Innovation Center Basel, Roche Pharma Research and Early Development, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jukofsky, Lori" sort="Jukofsky, Lori" uniqKey="Jukofsky L" first="Lori" last="Jukofsky">Lori Jukofsky</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chen, Gong" sort="Chen, Gong" uniqKey="Chen G" first="Gong" last="Chen">Gong Chen</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Martinelli, Giovanni" sort="Martinelli, Giovanni" uniqKey="Martinelli G" first="Giovanni" last="Martinelli">Giovanni Martinelli</name>
<affiliation><nlm:affiliation>Seragnoli Institute of Hematology, Bologna University School of Medicine, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhong, Hua" sort="Zhong, Hua" uniqKey="Zhong H" first="Hua" last="Zhong">Hua Zhong</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="So, W Venus" sort="So, W Venus" uniqKey="So W" first="W Venus" last="So">W Venus So</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dickinson, Michael J" sort="Dickinson, Michael J" uniqKey="Dickinson M" first="Michael J" last="Dickinson">Michael J. Dickinson</name>
<affiliation><nlm:affiliation>Department of Haematology, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Drummond, Mark" sort="Drummond, Mark" uniqKey="Drummond M" first="Mark" last="Drummond">Mark Drummond</name>
<affiliation><nlm:affiliation>Beatson West of Scotland Cancer Center, Gartnavel General Hospital, Glasgow, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Assouline, Sarit" sort="Assouline, Sarit" uniqKey="Assouline S" first="Sarit" last="Assouline">Sarit Assouline</name>
<affiliation><nlm:affiliation>Division of Hematology, Jewish General Hospital, McGill University, Montreal, QC, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hashemyan, Maneja" sort="Hashemyan, Maneja" uniqKey="Hashemyan M" first="Maneja" last="Hashemyan">Maneja Hashemyan</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Theron, Michel" sort="Theron, Michel" uniqKey="Theron M" first="Michel" last="Theron">Michel Theron</name>
<affiliation><nlm:affiliation>Roche Innovation Center Basel, Roche Pharma Research and Early Development, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Blotner, Steven" sort="Blotner, Steven" uniqKey="Blotner S" first="Steven" last="Blotner">Steven Blotner</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lee, Je Hwan" sort="Lee, Je Hwan" uniqKey="Lee J" first="Je-Hwan" last="Lee">Je-Hwan Lee</name>
<affiliation><nlm:affiliation>Department of Hematology, Asian Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kasner, Margaret" sort="Kasner, Margaret" uniqKey="Kasner M" first="Margaret" last="Kasner">Margaret Kasner</name>
<affiliation><nlm:affiliation>Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yoon, Sung Soo" sort="Yoon, Sung Soo" uniqKey="Yoon S" first="Sung-Soo" last="Yoon">Sung-Soo Yoon</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Seoul National University School of Medicine, Seoul, South Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rueger, Ruediger" sort="Rueger, Ruediger" uniqKey="Rueger R" first="Ruediger" last="Rueger">Ruediger Rueger</name>
<affiliation><nlm:affiliation>Roche Innovation Center Penzberg, Roche Pharma Research and Early Development, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Seiter, Karen" sort="Seiter, Karen" uniqKey="Seiter K" first="Karen" last="Seiter">Karen Seiter</name>
<affiliation><nlm:affiliation>New York Medical College, Valhalla, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Middleton, Steven A" sort="Middleton, Steven A" uniqKey="Middleton S" first="Steven A" last="Middleton">Steven A. Middleton</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kelly, Kevin R" sort="Kelly, Kevin R" uniqKey="Kelly K" first="Kevin R" last="Kelly">Kevin R. Kelly</name>
<affiliation><nlm:affiliation>University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vey, Norbert" sort="Vey, Norbert" uniqKey="Vey N" first="Norbert" last="Vey">Norbert Vey</name>
<affiliation><nlm:affiliation>Hematology, Institut Paoli Calmettes, Marseilles, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yee, Karen" sort="Yee, Karen" uniqKey="Yee K" first="Karen" last="Yee">Karen Yee</name>
<affiliation><nlm:affiliation>Princess Margaret Hospital, Toronto, ON, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Nichols, Gwen" sort="Nichols, Gwen" uniqKey="Nichols G" first="Gwen" last="Nichols">Gwen Nichols</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chen, Lin Chi" sort="Chen, Lin Chi" uniqKey="Chen L" first="Lin-Chi" last="Chen">Lin-Chi Chen</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pierceall, William E" sort="Pierceall, William E" uniqKey="Pierceall W" first="William E" last="Pierceall">William E. Pierceall</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA william.pierceall@roche.com.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26869629</idno>
<idno type="pmid">26869629</idno>
<idno type="doi">10.3324/haematol.2015.139717</idno>
<idno type="wicri:Area/PubMed/Corpus">001E84</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E84</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.</title>
<author><name sortKey="Reis, Bernhard" sort="Reis, Bernhard" uniqKey="Reis B" first="Bernhard" last="Reis">Bernhard Reis</name>
<affiliation><nlm:affiliation>Roche Innovation Center Basel, Roche Pharma Research and Early Development, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jukofsky, Lori" sort="Jukofsky, Lori" uniqKey="Jukofsky L" first="Lori" last="Jukofsky">Lori Jukofsky</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chen, Gong" sort="Chen, Gong" uniqKey="Chen G" first="Gong" last="Chen">Gong Chen</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Martinelli, Giovanni" sort="Martinelli, Giovanni" uniqKey="Martinelli G" first="Giovanni" last="Martinelli">Giovanni Martinelli</name>
<affiliation><nlm:affiliation>Seragnoli Institute of Hematology, Bologna University School of Medicine, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhong, Hua" sort="Zhong, Hua" uniqKey="Zhong H" first="Hua" last="Zhong">Hua Zhong</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="So, W Venus" sort="So, W Venus" uniqKey="So W" first="W Venus" last="So">W Venus So</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dickinson, Michael J" sort="Dickinson, Michael J" uniqKey="Dickinson M" first="Michael J" last="Dickinson">Michael J. Dickinson</name>
<affiliation><nlm:affiliation>Department of Haematology, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Drummond, Mark" sort="Drummond, Mark" uniqKey="Drummond M" first="Mark" last="Drummond">Mark Drummond</name>
<affiliation><nlm:affiliation>Beatson West of Scotland Cancer Center, Gartnavel General Hospital, Glasgow, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Assouline, Sarit" sort="Assouline, Sarit" uniqKey="Assouline S" first="Sarit" last="Assouline">Sarit Assouline</name>
<affiliation><nlm:affiliation>Division of Hematology, Jewish General Hospital, McGill University, Montreal, QC, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hashemyan, Maneja" sort="Hashemyan, Maneja" uniqKey="Hashemyan M" first="Maneja" last="Hashemyan">Maneja Hashemyan</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Theron, Michel" sort="Theron, Michel" uniqKey="Theron M" first="Michel" last="Theron">Michel Theron</name>
<affiliation><nlm:affiliation>Roche Innovation Center Basel, Roche Pharma Research and Early Development, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Blotner, Steven" sort="Blotner, Steven" uniqKey="Blotner S" first="Steven" last="Blotner">Steven Blotner</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lee, Je Hwan" sort="Lee, Je Hwan" uniqKey="Lee J" first="Je-Hwan" last="Lee">Je-Hwan Lee</name>
<affiliation><nlm:affiliation>Department of Hematology, Asian Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kasner, Margaret" sort="Kasner, Margaret" uniqKey="Kasner M" first="Margaret" last="Kasner">Margaret Kasner</name>
<affiliation><nlm:affiliation>Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yoon, Sung Soo" sort="Yoon, Sung Soo" uniqKey="Yoon S" first="Sung-Soo" last="Yoon">Sung-Soo Yoon</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Seoul National University School of Medicine, Seoul, South Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rueger, Ruediger" sort="Rueger, Ruediger" uniqKey="Rueger R" first="Ruediger" last="Rueger">Ruediger Rueger</name>
<affiliation><nlm:affiliation>Roche Innovation Center Penzberg, Roche Pharma Research and Early Development, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Seiter, Karen" sort="Seiter, Karen" uniqKey="Seiter K" first="Karen" last="Seiter">Karen Seiter</name>
<affiliation><nlm:affiliation>New York Medical College, Valhalla, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Middleton, Steven A" sort="Middleton, Steven A" uniqKey="Middleton S" first="Steven A" last="Middleton">Steven A. Middleton</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kelly, Kevin R" sort="Kelly, Kevin R" uniqKey="Kelly K" first="Kevin R" last="Kelly">Kevin R. Kelly</name>
<affiliation><nlm:affiliation>University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vey, Norbert" sort="Vey, Norbert" uniqKey="Vey N" first="Norbert" last="Vey">Norbert Vey</name>
<affiliation><nlm:affiliation>Hematology, Institut Paoli Calmettes, Marseilles, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yee, Karen" sort="Yee, Karen" uniqKey="Yee K" first="Karen" last="Yee">Karen Yee</name>
<affiliation><nlm:affiliation>Princess Margaret Hospital, Toronto, ON, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Nichols, Gwen" sort="Nichols, Gwen" uniqKey="Nichols G" first="Gwen" last="Nichols">Gwen Nichols</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chen, Lin Chi" sort="Chen, Lin Chi" uniqKey="Chen L" first="Lin-Chi" last="Chen">Lin-Chi Chen</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pierceall, William E" sort="Pierceall, William E" uniqKey="Pierceall W" first="William E" last="Pierceall">William E. Pierceall</name>
<affiliation><nlm:affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA william.pierceall@roche.com.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Haematologica</title>
<idno type="eISSN">1592-8721</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">26869629</PMID>
<DateCreated><Year>2016</Year>
<Month>05</Month>
<Day>02</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1592-8721</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>101</Volume>
<Issue>5</Issue>
<PubDate><Year>2016</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Haematologica</Title>
<ISOAbbreviation>Haematologica</ISOAbbreviation>
</Journal>
<ArticleTitle>Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.</ArticleTitle>
<Pagination><MedlinePgn>e185-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3324/haematol.2015.139717</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reis</LastName>
<ForeName>Bernhard</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center Basel, Roche Pharma Research and Early Development, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jukofsky</LastName>
<ForeName>Lori</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Gong</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Martinelli</LastName>
<ForeName>Giovanni</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Seragnoli Institute of Hematology, Bologna University School of Medicine, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhong</LastName>
<ForeName>Hua</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>So</LastName>
<ForeName>W Venus</ForeName>
<Initials>WV</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dickinson</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo><Affiliation>Department of Haematology, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Drummond</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Beatson West of Scotland Cancer Center, Gartnavel General Hospital, Glasgow, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Assouline</LastName>
<ForeName>Sarit</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Division of Hematology, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hashemyan</LastName>
<ForeName>Maneja</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Theron</LastName>
<ForeName>Michel</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center Basel, Roche Pharma Research and Early Development, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Blotner</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>Je-Hwan</ForeName>
<Initials>JH</Initials>
<AffiliationInfo><Affiliation>Department of Hematology, Asian Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kasner</LastName>
<ForeName>Margaret</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yoon</LastName>
<ForeName>Sung-Soo</ForeName>
<Initials>SS</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University School of Medicine, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rueger</LastName>
<ForeName>Ruediger</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center Penzberg, Roche Pharma Research and Early Development, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Seiter</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>New York Medical College, Valhalla, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Middleton</LastName>
<ForeName>Steven A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kelly</LastName>
<ForeName>Kevin R</ForeName>
<Initials>KR</Initials>
<AffiliationInfo><Affiliation>University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vey</LastName>
<ForeName>Norbert</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Hematology, Institut Paoli Calmettes, Marseilles, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yee</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Princess Margaret Hospital, Toronto, ON, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Nichols</LastName>
<ForeName>Gwen</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Lin-Chi</ForeName>
<Initials>LC</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pierceall</LastName>
<ForeName>William E</ForeName>
<Initials>WE</Initials>
<AffiliationInfo><Affiliation>Roche Innovation Center New York, Roche Pharma Research and Early Development, NY, USA william.pierceall@roche.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>02</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Italy</Country>
<MedlineTA>Haematologica</MedlineTA>
<NlmUniqueID>0417435</NlmUniqueID>
<ISSNLinking>0390-6078</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>EMBO Mol Med. 2011 Nov;3(11):623-36</RefSource>
<PMID Version="1">21953712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Elife. 2015 May 12;4:null</RefSource>
<PMID Version="1">25965177</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 2004 Feb 6;303(5659):844-8</RefSource>
<PMID Version="1">14704432</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2016 Feb 15;22(4):868-76</RefSource>
<PMID Version="1">26459177</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biomark Med. 2015;9(1):25-34</RefSource>
<PMID Version="1">25605453</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 2015 Nov;171(3):432-5</RefSource>
<PMID Version="1">25855517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2012 Nov;13(11):1133-40</RefSource>
<PMID Version="1">23084521</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1888-93</RefSource>
<PMID Version="1">16443686</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC5004378</OtherID>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AML</Keyword>
<Keyword MajorTopicYN="N">MDM2 antagonism</Keyword>
<Keyword MajorTopicYN="N">complementary diagnostics</Keyword>
<Keyword MajorTopicYN="N">flow cytometry</Keyword>
<Keyword MajorTopicYN="N">idasanutlin</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>2</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>2</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>2</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26869629</ArticleId>
<ArticleId IdType="pii">haematol.2015.139717</ArticleId>
<ArticleId IdType="doi">10.3324/haematol.2015.139717</ArticleId>
<ArticleId IdType="pmc">PMC5004378</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E84 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001E84 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:26869629
   |texte=   Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:26869629" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.

Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.

Source :

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki